| Literature DB >> 31625267 |
Mingzhe Sun1, Charlotta Turner1, Margareta Sandahl1.
Abstract
To circumvent the detrimental effects of large-volume injection with fixed-loop injector in modern supercritical fluid chromatography, the feasibility of performing multiple injection was investigated. By accumulating analytes from a certain number of continual small-volume injections, compounds can be concentrated on the column head, and this leads to signal enhancement compared with a single injection. The signal to noise enhancement of different compounds appeared to be associated with their retention on different stationary phases and with type of sample diluent. The diethylamine column gave the best signal to noise enhancement when acetonitrile was used as sample diluent and the 2-picolylamine column showed the best overall performance with water as the sample diluent. The advantage of multiple injection over one-time large-volume injection was proven with sulfanilamide, with both acetonitrile and water as sample diluents. The multiple injection approach exhibited comparable within- and between-day precision of retention time and peak area with those of single injections. The potential of the multiple injection approach was demonstrated in the analysis of sulfanilamide-spiked honey extract and diclofenac-spiked ground water sample. The limitations of this approach were also discussed.Entities:
Keywords: large injection volume; multiple injection; signal enhancement; supercritical fluid chromatography
Mesh:
Substances:
Year: 2019 PMID: 31625267 PMCID: PMC6972688 DOI: 10.1002/jssc.201900614
Source DB: PubMed Journal: J Sep Sci ISSN: 1615-9306 Impact factor: 3.645
Figure 1Calculation of the S/N enhancement ratio for a multiple injection analysis
S/N enhancement ratios compared with single injection on a 2‐PIC column (ACN as sample diluent)
| Compound | Fluo | Caf | Ibu | 4‐HBAlde | 3‐MCA | FA | p‐CA | Sulf |
|---|---|---|---|---|---|---|---|---|
| Retention time/min | 0.414 | 0.437 | 0.629 | 0.809 | 1.087 | 2.256 | 2.774 | 3.207 |
| Single injection | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| 2‐time injection | 1.0 | Split | 1.8 | Shoulder | 1.8 | 1.9 | 1.9 | 1.6 |
| 4‐time injection | 1.0 | ‐ | 2.3 | ‐ | 2.4 | 3.3 | 3.5 | 2.3 |
| 6‐time injection | 1.0 | ‐ | Shoulder | ‐ | 2.5 | 4.1 | 4.8 | 2.9 |
| 8‐time injection | 1.0 | ‐ | ‐ | ‐ | Shoulder | 4.5 | 5.7 | 3.5 |
| 10‐time injection | 1.0 | ‐ | ‐ | ‐ | ‐ | 4.8 | 6.5 | 3.9 |
| 14‐time injection | 1.0 | ‐ | ‐ | ‐ | ‐ | 5.7 | 7.5 | 4.5 |
| 20‐time injection | 1.0 | ‐ | ‐ | ‐ | ‐ | 6.9 | 8.8 | 5.6 |
Fluo, fluoranthene; Caf, caffeine; Ibu, ibuprofen; 4‐HBAlde, 4‐hydroxybenzaldehyde; 3‐MCA, 3‐methoxycinnamic acid; FA, ferulic acid; p‐CA, p‐coumaric acid; Sulf, sulfanilamide.
Retention times for single injection analysis.
Figure 2Plots of S/N enhancement ratio vs. number of accumulated injections with ACN as sample diluent (retention times of each compound is written besides the compound names)
Figure 3S/N enhancement and compound retention on the DEA and the 2‐PIC columns for different number of accumulated injections
Figure 4Plots of S/N enhancement ratio versus number of accumulated injections on different columns with H2O as a sample diluent (retention times of each compound is written besides the compound names)
S/N enhancement ratios for large‐volume single injection as compared to multiple injections
|
| ||||
|---|---|---|---|---|
| Single 20 µL injection | Multiple 3 µL × 6 injection | Single 40 µL injection | Multiple 3 µL × 14 injection | |
| Sulfanilamide | 1.93 | 4.91 | 3.16 | 9.52 |
| p‐Coumaric acid | 4.79 | 5.10 | 8.98 | 9.88 |
Three microliter single injections were used.
Repeatability of multiple injection with respect to retention time and peak area
| RSD of retention time (%) | ||||||||
|---|---|---|---|---|---|---|---|---|
| 3‐methoxycinnamic acid | Sulfanilamide | Ferulic acid | p‐Coumaric acid | |||||
| Within‐day | Between‐day | Within‐day | Between‐day | Within‐day | Between‐day | Within‐day | Between‐day | |
| Single 3 µL injection | 0.070 | 1.5 | 0.21 | 0.52 | 0.22 | 0.71 | 0.078 | 0.41 |
| 4‐time 3 µL injection | 0.13 | 1.4 | 0.23 | 0.61 | 0.088 | 0.68 | 0.051 | 0.49 |
| 8‐time 3 µL injection | 0.080 | 1.3 | 0.12 | 0.89 | 0.047 | 0.59 | 0.043 | 0.41 |
| 12‐time 3 µL injection | 0.081 | 1.2 | 0.052 | 1.1 | 0.061 | 0.61 | 0.042 | 0.49 |
Figure 5Multiple injection of sulfanilamide spiked (500 ng/mL) honey extract in ACN
Figure 6(A) S/N enhancement of diclofenac in ground water on different columns; (B) Multiple injection of diclofenac spiked (1 µg/mL) ground water sample on the 2‐PIC column